Minnesota Issues Second Annual Report on 340B Revenue; Expands Scope to Additional Settings 

Screenshot of report.
The Minnesota Department of Health on Feb. 27 released its second 340B Covered Entity Report.
Minnesota hospitals and covered entities brought in at least $1.34 billion in collective net 340B program revenue in 2024, according [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

More Transparency, Savings-Preserving Policies Recommended to Maintain Medicaid Savings in Health Affairs Article

A screenshot of the Health Affairs article, When Safety-Net Programs Compete: Medicaid, 340B, And The Battle Over Drug Discounts.
A prominent 340B researcher suggested various state policies to preserve Medicaid savings in a recent Health Affairs article.
States should improve transparency and enact “savings-preserving polices”—like 340B carve-outs or acquisition cost-based reimbursements—to prevent the 340B program from unintentionally [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Legacy Health Endowment White Paper Calls for More 340B Provider Transparency, Protection of Contract Pharmacies

The Legacy Health Endowment, a private foundation, recently published a white paper on the 340B program.
A new white paper from the private foundation Legacy Health Endowment (LHE) called on Congress to establish clearer 340B program [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Commonwealth Fund Explainer Highlights Key Issues Surrounding 340B Program and Potential Reforms

An Aug. 6 Commonwealth Fund explainer looked at the state of the 340B program and potential reforms.
A prestigious health care think tank recently offered an overview of the 340B program—including criticisms surrounding its growth and drugmakers’ [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AHA Report: 340B Hospitals Face More Federal Oversight, Fare Better in Audits; HRSA Releases Latest Drugmaker Audit

A new AHA analysis found that 340B hospitals face more federal oversight and routinely see higher rates of compliance in federal audits than drugmakers.
Hospitals that participate in the 340B program face more federal oversight and routinely see higher rates of compliance in federal [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drug-Industry Funded Study Finds Utilization Drives 340B Program Growth, Not Rising Drug Prices

A recent drug-industry funded study in Health Affairs Scholar found that increased utilization, rather than rising drug prices, drives 340B program growth.
A recent drug-industry-funded study attributes the 340B program’s recent growth to increased utilization—not rising drug prices. The May 21 study, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospital Group-Funded Working Paper Calls for Increased 340B Visibility Among Economists 

A recent working paper called for more economists to study the 340B program, which could broaden policymakers' understanding of its impact.
There’s a gap in economics research on the 340B program, and economists could enrich 340B stakeholders’ understanding of the program [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drug Industry-Funded White Paper Ties 340B to Rising Commercial Insurance Premiums; Provider Advocates Criticize Study

A recent drug industry-funded white paper drew a connection between 340B and increases in commercial insurance premiums, but provider advocates and attorneys criticized its methodology and findings.
The 340B program is driving up employer-sponsored health insurance premiums, according to a drug industry-funded white paper. Provider advocates criticized [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Trump-Aligned Think Tank Proposes Lowering U.S. Drug Prices Through IRA and Other Policies, Doesn’t Weigh In on 340B Program

America First Policy Institute released a March 21 brief detailing how policymakers “could accelerate drug development and enhance patient health by implementing reforms that discourage other countries from freeloading off American drug innovation.”
A conservative think tank, which officials who served in President Donald Trump’s (R) first administration founded to advance his priorities, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Misinformation Makes Up Small Part of 340B Conversations Online, But Garners Outsized Attention, Analysis Finds

Storyful Rx analyzed more than 6,000 social media posts and articles mentioning the 340B program between Aug. 11, 2024 and Feb. 11, 2025.
Although misinformation accounts for just 2% of the overall 340B conversations taking place online, “conspiratorial narratives” driven by conservative influencers—and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live